QT
NMTR

Quantbot Technologies’s 9 Meters Biopharma NMTR Stock Holding History

Quantbot Technologies’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-62
Closed -$8K – 1516
2018
Q3 		$8K Buy
+62
New +$10.7K ﹤0.01% 1187

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Quantbot Technologies's NMTR Position: Q4 2018 in Review

Quantbot Technologies sold out of 9 Meters Biopharma (NMTR) in Q4 2018, closing a stake of 62 shares — an estimated $8K sold.

Quantbot Technologies first reported a position in NMTR in Q3 2018 and held it in 1 quarter. The position peaked at $8K in Q3 2018. 39 funds tracked by Wall St. Rank hold NMTR as of Q4 2018.

  • Quantbot Technologies reported no remaining 9 Meters Biopharma position as of Q4 2018 after selling out during the quarter.
  • Quantbot Technologies sold 62 9 Meters Biopharma shares in Q4 2018, an estimated $8K.
  • Quantbot Technologies first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 1 quarter.
  • Quantbot Technologies's 9 Meters Biopharma position peaked at $8K in Q3 2018.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2018.

Based on Quantbot Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.